Potassium channel modulators and schizophrenia: an overview of investigational drugs.

Musselman, Meghan; Huynh, Eric; Kelshikar, Rachana; Lee, Eric; Malik, Mohammed; Faden, Justin

Musselman, Meghan; Huynh, Eric; Kelshikar, Rachana; Lee, Eric; Malik, Mohammed; Faden, Justin.

Afiliación

Musselman M; Department of Psychiatry, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Huynh E; Department of Psychiatry, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Kelshikar R; Department of Psychiatry, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Lee E; Department of Psychiatry, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Malik M; Department of Psychiatry, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Faden J; Department of Psychiatry, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.

Expert Opin Investig Drugs ; 32(6): 471-477, 2023.

Article en En | MEDLINE | ID: mdl-37247333

Asunto(s)

Canales de Potasio; Esquizofrenia; Humanos; Canales de Potasio/fisiología; Drogas en Investigación/farmacología; Drogas en Investigación/uso terapéutico; Esquizofrenia/tratamiento farmacológico; Ácido gamma-Aminobutírico; Receptores Dopaminérgicos

Palabras clave

AUT00206; NMDA receptor; Schizophrenia; gamma oscillations; glutamate; potassium channel modulators; psychopharmacology

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Canales de Potasio Límite: Humans Idioma: En Revista: Expert Opin Investig Drugs Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google